Microbix Schedules Release of Results for Q3 Fiscal 2024

August 7, 2024

MISSISSAUGA, Ontario, Aug. 07, 2024 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX:MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it expects to file the financial statements and management disclosure and analysis for its third quarter of fiscal 2024 ended June 30, 2024 (“Q3 2024”) prior to the start of trading on August 14, 2024. Furthermore, at 10:00 AM ET on that day, Microbix intends to hold a webinar discussion of Q3 2024 results with its CEO, CFO, and COO.

Read more at globenewswire.com

Related news for (MBXBF)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.